Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/30093
Type
ArticleCopyright
Restricted access
Embargo date
2028-08-30
Collections
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
SEROPREVALENCE OF HPV VACCINE TYPES 6, 11, 16 AND 18 IN HIV-INFECTED WOMEN FROM SOUTH AFRICA, BRAZIL AND BOTSWANA
Author
Affilliation
University of Witwatersrand. Faculty of Health Science Center. Department of Medicine. Clinical HIV Research Unit. Johannesburg, South Africa./ Right to Care. Johannesburg, South Africa.
University of Witwatersrand. Faculty of Health Science Center. Department of Medicine. Clinical HIV Research Unit. Johannesburg, South Africa.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Right to Care. Johannesburg, South Africa.
University of the Witwatersrand. Faculty of Health Sciences. Department of Anatomical Pathology. Cytology Unit. Johannesburg, South Africa./ National Health Laboratory Service. Johannesburg, South Africa.
University of Botswana. School of Medicine. Gaborone, Botswana./ Botswana-Harvard School of Public Health AIDS Initiative Partnership. Gaborone, Botswana.
Botswana-Harvard School of Public Health AIDS Initiative Partnership. Gaborone, Botswana.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Botswana-Harvard School of Public Health AIDS Initiative Partnership. Gaborone, Botswana./ Brigham and Women’s Hospital. Boston, MA, United States.
University of Witwatersrand. Faculty of Health Science Center. Department of Medicine. Clinical HIV Research Unit. Johannesburg, South Africa.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Right to Care. Johannesburg, South Africa.
University of the Witwatersrand. Faculty of Health Sciences. Department of Anatomical Pathology. Cytology Unit. Johannesburg, South Africa./ National Health Laboratory Service. Johannesburg, South Africa.
University of Botswana. School of Medicine. Gaborone, Botswana./ Botswana-Harvard School of Public Health AIDS Initiative Partnership. Gaborone, Botswana.
Botswana-Harvard School of Public Health AIDS Initiative Partnership. Gaborone, Botswana.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Botswana-Harvard School of Public Health AIDS Initiative Partnership. Gaborone, Botswana./ Brigham and Women’s Hospital. Boston, MA, United States.
Abstract
Many resource limited settings (RLS) suffer from high rates of both cervical cancer and HIV. Limited HPV serology data are available from RLS; such data could help describe local patterns of HPV infection and predict vaccine efficacy.
Share